StockData

Aspira Women's Health Inc. (AWHL) stock

AWHLOTCIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 1/30
$0.22−0.01 (-2.61%)

Close on Oct 19, 2026Market cap $9.91MP/E –Yield –

Aspira Women's Health price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Aspira Women's Health's price to sales ratio was 61.4× on Oct 19, 2026, against 0.1× a year earlier. Over the last 5 years it ranged from 0.1× to 205.6×, with a median of 9.2×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Oct 19, 202661.4×+61.4
2025Jan 31, 20250.1×−0.1
2024Dec 31, 20240.1×−4.4
2023Dec 29, 20234.6×−0.6
2022Dec 30, 20225.2×−25.8
2021Dec 31, 202131.0×−123.7
2020Dec 31, 2020154.7×+135.7
2019Dec 31, 201919.0×+11.2
2018Dec 31, 20187.7×−29.3
2017Dec 29, 201737.0×+14.4
2016Dec 30, 201622.6×−5.1
2015Dec 31, 201527.7×−0.6
2014Dec 31, 201428.2×+2.1
2013Dec 31, 201326.1×+15.3
2012Dec 31, 201210.8×−1.6
2011Dec 30, 201112.4×–

More Aspira Women's Health figures

See a number that looks wrong?